CLDX CIK: 744218

Celldex Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
0.41
FY22:
0.32
FY23:
0.43
FY24:
0.75
FY25:
0.53
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.03
FY22:
0.04
FY23:
0.03
FY24:
0.05
FY25:
0.05
Total assets
Change from FY21 to FY25
billions USD
FY21:
0.44
FY22:
0.35
FY23:
0.47
FY24:
0.79
FY25:
0.58

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.02
FY22:
0.02
FY23:
0.03
FY24:
0.04
FY25:
0.05
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.01
FY22:
0.01
FY23:
0.01
FY24:
0.01
FY25:
0.00
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.42
FY22:
0.33
FY23:
0.43
FY24:
0.75
FY25:
0.53
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
0.44
FY22:
0.35
FY23:
0.47
FY24:
0.79
FY25:
0.58

All amounts in billions USD Data source:SEC EDGAR